NCT00184639View on ClinicalTrials.gov

Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes

PHASE3CompletedINTERVENTIONAL

Enrollment

71

Participants

Timeline

Start Date

August 16, 2004

Primary Completion Date

November 22, 2005

Study Completion Date

November 22, 2005

Conditions

DiabetesDiabetes Mellitus, Type 1

Interventions

DRUG

insulin detemir

Trial Locations (2)

13353

Novo Nordisk Investigational Site, Berlin

30173

Novo Nordisk Investigational Site, Hanover

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY